Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 3 5Phase NA 4Phase 4 3Phase 2/3 1Phase 1/2 1

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Breast 1

Conditions

Vomiting 4Nausea 4Sarcoma 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Aprepitant 8Dexamethasone 7Calcium Dobesilate 7Ondansetron 6dexamethasone acetate 5Therapeutics 5Doxorubicin 5Vincristine 4Palonosetron 4Cyclophosphamide 4dexamethasone 21-phosphate 3Psychiatric Rehabilitation 3Granisetron 3peppermint oil 2auricularum 2Yoga 2Rituximab 2Music Therapy 2Mesna 2Lorazepam 2Ifosfamide 2Control Groups 2Aromatherapy 2Acupressure 2stinging nettle lectin 1salicylhydroxamic acid 1fosaprepitant 1dolasetron 1almond oil 1Whole Body Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × Nausea × Palonosetron × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT05690802 2023-01-19

TSEPHCC

Xijing Hospital

Phase NA Recruiting
1,060 enrolled

Nausea, Vomiting

NCT00343863 2017-07-11

Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast Cancer

University of Washington

Phase NA Completed
41 enrolled 12 charts
Breast

Breast Neoplasms, Nausea, Vomiting, Breast Neoplasms, Male

NCT00410488 2013-03-22

Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)

M.D. Anderson Cancer Center

Phase NA Completed
51 enrolled 5 charts
Sarcoma

Nausea, Sarcoma, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡